RNA‐interference‐mediated Cdc42 silencing down‐regulates phosphorylation of STAT3 and suppresses growth in human bladder‐cancer cells

Fuguo Wu,Yirong Chen,Yuan Li,Jun Ju,Zhiping Wang,D. Yan
DOI: https://doi.org/10.1042/BA20070107
2008-02-01
Biotechnology and Applied Biochemistry
Abstract:Cdc42 (cell division cycle 42), a member of Rho GTPases, is involved in cell transformation, proliferation, survival, invasion and metastasis of human cancer cells. Here, RNAi (RNA interference)‐mediated gene silencing was used to investigate the roles of Cdc42 and to assess its therapeutic potential in human bladder cancer. The results showed that Cdc42 silencing resulted in a marked reduction of Cdc42 mRNA and protein expression and a significant inhibition of cell proliferation from G0/G1‐ to S‐phase in two (EJ and T24) human bladder‐cancer cell lines. Moreover, RNAi‐mediated inhibition of Cdc42 induced apoptosis of EJ cells 96 h after transfection. In addition, we found that silencing of Cdc42 could down‐regulate the level of phosphorylated STAT3 (signal transducer and activator of transcription 3), but did not influence the level of total STAT3 in the two bladder‐cancer cell lines. These results suggest that RNAi‐mediated Cdc42 silencing may be a novel approach for gene therapy of bladder cancer.
What problem does this paper attempt to address?